Stock-based compensation decreased 40.4%
Stock-based compensation changed -40.4% from the comparable as-filed period.
$29.3M→$17.5M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →NVCR financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
SBC / revenue moved 850 bp lower
SBC / revenue changed -850 basis points from the comparable as-filed period.
17.54%→9.04%2 prior comparisons
Gross profit increased 21.6%
Gross profit changed +21.6% from the comparable as-filed period.
$122.5M→$148.9M2 prior comparisons
Current ratio increased 60.9%
Current ratio changed +60.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
1.55→2.494 prior comparisons
Working capital / assets moved 1748 bp higher
Working capital / assets changed +1748 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
31.14%→48.61%4 prior comparisons
Receivables / revenue moved 500 bp higher
Receivables / revenue changed +500 basis points from the comparable as-filed period.
50.97%→55.98%2 prior comparisons
Inventory / revenue moved 239 bp lower
Inventory / revenue changed -239 basis points from the comparable as-filed period.
23.39%→21.00%2 prior comparisons
Operating cash flow increased 10.2%
Operating cash flow changed +10.2% from the comparable as-filed period.
$20.6M→$22.7M2 prior comparisons
R&D / revenue moved 227 bp lower
R&D / revenue changed -227 basis points from the comparable as-filed period.
32.31%→30.04%2 prior comparisons
Working capital decreased 5.0%
Working capital changed -5.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$423.8M→$402.9M4 prior comparisons
Free-cash-flow proxy increased 5.5%
Free-cash-flow proxy changed +5.5% from the comparable as-filed period.
$14.9M→$15.7M2 prior comparisons
Capital expenditure increased 22.4%
Capital expenditure changed +22.4% from the comparable as-filed period.
$5.7M→$6.9M2 prior comparisons
Research & development increased 7.5%
Research & development changed +7.5% from the comparable as-filed period.
$54.0M→$58.1M2 prior comparisons
Capex / revenue moved 20 bp higher
Capex / revenue changed +20 basis points from the comparable as-filed period.
3.38%→3.58%2 prior comparisons
Free-cash-flow margin moved 78 bp lower
Free-cash-flow margin changed -78 basis points from the comparable as-filed period.
8.92%→8.14%2 prior comparisons
Inventory increased 3.8%
Inventory changed +3.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$39.1M→$40.6M4 prior comparisons
Cost of revenue decreased 0.4%
Cost of revenue changed -0.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$44.7M→$44.5M2 prior comparisons
Operating cash-flow margin moved 58 bp lower
Operating cash-flow margin changed -58 basis points from the comparable as-filed period.
12.30%→11.72%2 prior comparisons
SBC / revenue moved 720 bp lower
SBC / revenue changed -720 basis points from the comparable as-filed period.
16.46%→9.27%2 prior comparisons
Gross profit increased 21.4%
Gross profit changed +21.4% from the comparable as-filed period.
$117.3M→$142.5M2 prior comparisons
Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed +105.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$21.4M→$1.2M2 prior comparisons
Stock-based compensation decreased 34.9%
Stock-based compensation changed -34.9% from the comparable as-filed period.
$26.1M→$17.0M2 prior comparisons
R&D / revenue moved 713 bp lower
R&D / revenue changed -713 basis points from the comparable as-filed period.
35.16%→28.02%2 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed +151.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$15.9M→$8.1M2 prior comparisons
Working capital / assets moved 2576 bp higher
Working capital / assets changed +2576 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
26.78%→52.54%4 prior comparisons
Receivables / revenue moved 262 bp lower
Receivables / revenue changed -262 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
56.62%→54.00%2 prior comparisons
Inventory / revenue moved 232 bp lower
Inventory / revenue changed -232 basis points from the comparable as-filed period.
25.32%→23.00%2 prior comparisons
Free-cash-flow margin moved 1415 bp higher
Free-cash-flow margin changed +1415 basis points from the comparable as-filed period.
-13.49%→0.66%2 prior comparisons
Operating cash-flow margin moved 1446 bp higher
Operating cash-flow margin changed +1446 basis points from the comparable as-filed period.
-10.03%→4.43%2 prior comparisons
Capital expenditure increased 26.1%
Capital expenditure changed +26.1% from the comparable as-filed period.
$5.5M→$6.9M2 prior comparisons
Trade receivables increased 10.2%
Trade receivables changed +10.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$89.9M→$99.1M4 prior comparisons
Research & development decreased 7.9%
Research & development changed -7.9% from the comparable as-filed period.
$55.8M→$51.4M2 prior comparisons
Inventory increased 5.0%
Inventory changed +5.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$40.2M→$42.2M4 prior comparisons
Capex / revenue moved 31 bp higher
Capex / revenue changed +31 basis points from the comparable as-filed period.
3.45%→3.77%2 prior comparisons
Cost of revenue decreased 0.9%
Cost of revenue changed -0.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$41.5M→$41.1M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.